NYSE:ABT - Abbott Laboratories Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $77.97 -2.09 (-2.61 %) (As of 03/22/2019 04:00 PM ET)Previous Close$77.97Today's Range$77.69 - $80.0052-Week Range$56.81 - $80.49Volume7.53 million shsAverage Volume5.89 million shsMarket Capitalization$136.95 billionP/E Ratio27.07Dividend Yield1.60%Beta1.13 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Abbott Laboratories (NYSE:ABT) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.18 Wall Street analysts have issued ratings and price targets for Abbott Laboratories in the last 12 months. Their average twelve-month price target is $79.6938, suggesting that the stock has a possible upside of 2.21%. The high price target for ABT is $90.00 and the low price target for ABT is $68.00. There are currently 1 sell rating, 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.722.722.812.84Ratings Breakdown: 1 Sell Rating(s)3 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)3 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)17 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)16 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $79.6938$79.4438$75.9050$70.7647Price Target Upside: 2.21% upside9.08% upside8.82% upside2.48% upsideAbbott Laboratories (NYSE:ABT) Consensus Price Target History Abbott Laboratories (NYSE:ABT) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails3/14/2019Wells Fargo & CoReiterated RatingBuyHigh3/8/2019BarclaysSet Price TargetBuy$84.00Low2/7/2019Bank of AmericaReiterated RatingBuy ➝ Buy$73.00 ➝ $81.00Low1/25/2019ArgusBoost Price TargetBuy ➝ In-Line$90.00Low1/24/2019BTIG ResearchReiterated RatingHoldMedium1/2/2019GabelliReiterated RatingBuyLow1/2/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$82.00 ➝ $85.00Low1/2/2019CitigroupDowngradeNeutral ➝ Sell$72.00 ➝ $68.00High12/17/2018Credit Suisse GroupInitiated CoverageOutperform$82.00Low12/9/2018Goldman Sachs GroupUpgradeNeutral ➝ Buy$74.10Low11/27/2018UBS GroupInitiated CoverageBuy$83.00High10/18/2018Jefferies Financial GroupReiterated RatingIn-Line ➝ Buy$80.00High10/18/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$77.00 ➝ $79.00High10/11/2018Royal Bank of CanadaBoost Price TargetOutperform$77.00Low10/8/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$77.00 ➝ $81.00Low10/5/2018CowenBoost Price TargetOutperform ➝ Average$72.00 ➝ $86.00Low7/19/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$71.00 ➝ $72.00Medium6/27/2018Sanford C. BernsteinInitiated CoverageOutperform$73.00Medium1/25/2018GuggenheimReiterated RatingBuy$72.00Low1/25/2018Leerink SwannReiterated RatingMarket Perform$60.00 ➝ $68.00Low1/25/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$65.00 ➝ $70.00Medium1/25/2018William BlairUpgradeMarket Perform ➝ OutperformMedium1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$64.00Low(Data available from 3/23/2017 forward) This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: What Does a Sell-Side Analyst Rating Mean?